The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Aminoglycosides: An Overview
Open accessAbstract
Aminoglycosides are natural or semisynthetic antibiotics derived from actinomycetes. They were among the first antibiotics to be introduced for routine clinical use and several examples have been approved for use in humans. They found widespread use as first-line agents in the early days of antimicrobial chemotherapy, but were eventually replaced in the 1980s with cephalosporins, carbapenems, and fluoroquinolones. Aminoglycosides synergize with a variety of other antibacterial classes, which, in combination with the continued increase in the rise of multidrug-resistant bacteria and the potential to improve the safety and efficacy of the class through optimized dosing regimens, has led to a renewed interest in these broad-spectrum and rapidly bactericidal antibacterials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
Tularemia as a Biological Weapon: Medical and Public Health Management
Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Friedlander, A. M., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.21.2763 · Cited by 1,412
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Aminoglycosides: Activity and Resistance
Mingeot-Leclercq, M.-P., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,113
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Bacterial uptake of aminoglycoside antibiotics
Taber, H. W., Mueller, J. P., Miller, P. F., & Arrow, A. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.4.439-457.1987 · Cited by 598
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
ALTERATIONS IN OUTER MEMBRANE PERMEABILITY
Hancock, R. E. W. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.001321 · Cited by 564
Injectable Paromomycin for Visceral Leishmaniasis in India
Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
HOW ANTIBIOTIC-PRODUCING ORGANISMS AVOID SUICIDE
Cundliffe, E. (1989) · Annual Review of Microbiology · doi:10.1146/annurev.mi.43.100189.001231 · Cited by 421
Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides
MOORE, R. D., SMITH, C. R., LIPSKY, J. J., MELLITS, E. D., & LIETMAN, P. S. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-3-352 · Cited by 416
Falzon, D., Jaramillo, E., & Schünemann, H. J. (2011) · European Respiratory Journal · doi:10.1183/13993003/erj.38.suppl_55.393 · Cited by 393
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Once versus thrice daily gentamicin in patients with serious infections
Prins, J. M., Buller, H. R., Speelman, P., Kuijper, E. J., & Tange, R. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90137-6 · Cited by 350
Sundar, S., Sinha, P. K., Rai, M., Verma, D. K., Nawin, K., Alam, S., Chakravarty, J., Vaillant, M., Verma, N., Pandey, K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62050-8 · Cited by 337
Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria
Courvalin, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1447 · Cited by 327
Price, R., MacLennan, G., Glen, J., & on behalf of the SuDDICU collaboration (2014) · BMJ · doi:10.1136/bmj.g2197 · Cited by 298
Davis, B. D., Chen, L. L., & Tai, P. C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6164 · Cited by 293
Daneman, N., Sarwar, S., Fowler, R. A., & Cuthbertson, B. H. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70322-5 · Cited by 288
Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally
Eliopoulos, G. M., Drusano, G. L., Ambrose, P. G., Bhavnani, S. M., Bertino, J. S., Nafziger, A. N., & Louie, A. (2007) · Clinical Infectious Diseases · doi:10.1086/520991 · Cited by 266
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae
Swenson, J. M., Wallace, R. J., Silcox, V. A., & Thornsberry, C. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.6.807 · Cited by 258
AcrD of Escherichia coli Is an Aminoglycoside Efflux Pump
Rosenberg, E. Y., Ma, D., & Nikaido, H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1754-1756.2000 · Cited by 256
Wachino, J., & Arakawa, Y. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.05.001 · Cited by 255
Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.007 · Cited by 248
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa
Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H., & Arakawa, Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14959-8 · Cited by 242
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
Craig, W. A., Redington, J., & Ebert, S. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.29 · Cited by 238
Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity
Avent, M. L., Rogers, B. A., Cheng, A. C., & Paterson, D. L. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02452.x · Cited by 231
Hancock, R. E., Raffle, V. J., & Nicas, T. I. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.5.777 · Cited by 219
Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenyltransferase
Hollingshead, S., & Vapnek, D. (1985) · Plasmid · doi:10.1016/0147-619x(85)90052-6 · Cited by 211
Tobramycin: A Review of its Antibacterial and Pharmacokinetic Properties and Therapeutic Use
Brogden, R. N., Pinder, R. M., Sawyer, P. R., Speight, T. M., & Avery, G. S. (1976) · Drugs · doi:10.2165/00003495-197612030-00002 · Cited by 195
Antibiotic combinations: should they be tested?
Eliopoulos, G. M., & Eliopoulos, C. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.139 · Cited by 189
Doi, Y., Yokoyama, K., Yamane, K., Wachino, J.-I., Shibata, N., Yagi, T., Shibayama, K., Kato, H., & Arakawa, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.491-496.2004 · Cited by 187
Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium
Costa, Y., Galimand, M., Leclercq, R., Duval, J., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1896 · Cited by 185
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr226 · Cited by 182
rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi
Schwartz, J. J., Gazumyan, A., & Schwartz, I. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.11.3757-3765.1992 · Cited by 181
Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides
Beauclerk, A. A. D., & Cundliffe, E. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90349-4 · Cited by 181
Hancock, R. E., Farmer, S. W., Li, Z. S., & Poole, K. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1309 · Cited by 180
Wachino, J.-I., Shibayama, K., Kurokawa, H., Kimura, K., Yamane, K., Suzuki, S., Shibata, N., Ike, Y., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00926-07 · Cited by 180
Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1371-1375.2003 · Cited by 177
Llano-Sotelo, B., Azucena, E. F., Kotra, L. P., Mobashery, S., & Chow, C. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00125-4 · Cited by 167
Experience with a once-daily dosing program of aminoglycosides in critically ill patients
Buijk, S. L. C. E., Mouton, J. W., Gyssens, I. C., Verbrugh, H. A., & Bruining, H. A. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1313-7 · Cited by 162
Aminoglycoside phosphotransferases: proteins, structure, and mechanism
Gerard, D. W. (1999) · Frontiers in bioscience · doi:10.2741/wright · Cited by 159
Plasmid-Mediated Quinolone Resistance in Gram-Negative Bacterial Species: An Update
Cattoir, V., & Nordmann, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581879 · Cited by 153
Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
SenkaDZIDIC, & VladimirBEDEKOVIC (2003) · PubMed · Cited by 152
Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
Džidić, S., & Bedeković, V. (2003) · PubMed · Cited by 151
Clinical and Path ophysiologic Aspects of Aminoglycoside Nephrotoxicity
Humes, H. D., Weinberg, J. M., & Knauss, T. C. (1982) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(82)80039-5 · Cited by 145
Efflux pump-mediated drug resistance in Burkholderia
Podnecky, N. L., Rhodes, K. A., & Schweizer, H. P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00305 · Cited by 143
Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition
Azucena, E., & Mobashery, S. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0197 · Cited by 142
R‐factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics
Benveniste, R. Ė., & DAVIES, J. E. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80282-x · Cited by 139
Murphy, E. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00383309 · Cited by 132
Treatment of Plague with Gentamicin or Doxycycline in a Randomized Clinical Trial in Tanzania
Mwengee, W., Butler, T., Mgema, S. G., Mhina, G., Almasi, Y., Bradley, C., Formanik, J. B., & Rochester, C. G. (2006) · Clinical Infectious Diseases · doi:10.1086/500137 · Cited by 125
In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals
Ikäheimo, I., Syrjälä, H., Karhukorpi, J., Schildt, R., & Koskela, M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.287 · Cited by 124
Once Daily Aminoglycoside Therapy
Barclay, M. L., Kirkpatrick, C. M. J., & Begg, E. J. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936020-00001 · Cited by 121
Combating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
González-Padilla, M., Torre‐Cisneros, J., Rivera-Espinar, F., Pontes-Moreno, A., López‐Cerero, L., Pascual, Á., Natera, C., Rodriguez, M., Salcedo-Leal, I., Rodríguez-López, F., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku432 · Cited by 104
Berçot, B., Poirel, L., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.08.016 · Cited by 103
Resistance surveillance program report for selected European nations (2011)
Jones, R. N., Flonta, M., Gurler, N., Cepparulo, M., Mendes, R. E., & Castanheira, M. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.10.008 · Cited by 101
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
Sawicki, G. S., Signorovitch, J., Zhang, J., Latrémouille-Viau, D., von Wartburg, M., Wu, E. Q., & Shi, L. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21521 · Cited by 101
Pharmacodynamic Characterization of Nephrotoxicity Associated with Once‐Daily Aminoglycoside
Murry, K. R., McKinnon, P. S., Mitrzyk, B. M., & Rybak, M. J. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.16.1252.30876 · Cited by 101
Craig, W. A. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.006 · Cited by 99
Conjugative transfer in the dissemination of beta-lactam and aminoglycoside resistance
Virginia, L. W. (1999) · Frontiers in bioscience · doi:10.2741/waters · Cited by 96
Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci
Ounissi, H., Derlot, E., Carlier, C., & Courvalin, P. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2164 · Cited by 94
Skeggs, P. A., Thompson, J., & Cundliffe, E. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00425725 · Cited by 91
Ioannidou, E., Siempos, I. Ι., & Falagas, M. E. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm385 · Cited by 89
Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa
Islam, S., Jalal, S., & Wretlind, B. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00991.x · Cited by 79
Aminoglycosides: how should we use them in the 21st century?
Jackson, J., Chen, C., & Buising, K. L. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000012 · Cited by 74
In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics
Melchior, N. H., & Keiding, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.1.29 · Cited by 71
Outbreak Caused by NDM-1- and RmtB-Producing Escherichia coli in Bulgaria
Poirel, L., Savov, E., Nazlı, A., Trifonova, A., Тодорова, И., Gergova, I., & Nordmann, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02571-13 · Cited by 50
Kim, C. K., & Mobashery, S. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.11.001 · Cited by 40
AL-SHEIKH, Y. A., Marie, M. A. M., John, J., Krishnappa, L. G., & Dabwan, K. H. M. (2014) · Libyan Journal of Medicine · doi:10.3402/ljm.v9.24432 · Cited by 39
Selective decontamination and antibiotic resistance in ICUs
Plantinga, N. L., & Bonten, M. J. M. (2015) · Critical Care · doi:10.1186/s13054-015-0967-9 · Cited by 36
Abis, G. S. A., Stockmann, H. B. A. C., van Egmond, M., Bonjer, H. J., Vandenbroucke‐Grauls, C. M. J. E., & Oosterling, S. J. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2379-y · Cited by 17
What Would We Do Without Metronidazole?
Stover, K. R., Riche, D. M., Gandy, C. L., & Henderson, H. M. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182254bd6 · Cited by 13
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae
Wang, G., Zhao, G., Chao, X., Xie, L., & Wang, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176278 · Cited by 591
Post-stress bacterial cell death mediated by reactive oxygen species
Hong, Y., Zeng, J., Wang, X., Drlica, K., & Zhao, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901730116 · Cited by 513
Metadata
- Authors
- Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-06
- Volume
- 6
- Issue
- 6
- Pages
- a027029
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2416290591
- Cited by
- 1,149
- References
- 90
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.